This latest research indicates that such inhibition of the key enzymes leads to “increased plasma nicotine levels per cigarette smoked and a reduction in the number of cigarettes smoked, thus diminishing the adverse health effects of smoking.”
“Further investigations will be required to determine the potential for CBD and potentially other cannabinoids as agents for tobacco cessation therapy,” the study says.
From a harm reduction perspective, the implications of this study could be significant. Nicotine is a highly addictive substance, and even offsetting craving by a small amount could have demonstrable public health impacts.
Tobacco use has already been declining precipitously among the public. Gallup released a poll last year that found young people are now more than twice as likely to report smoking marijuana compared to cigarettes, for example.
